Jin Medical International Ltd. (ZJYL)
↓ Download CSV- Sector Manufacturing
- Incorporated E9
- Fiscal year ends Sep 30
In fiscal 2025, Jin Medical International Ltd. reported revenue of $20.69M, down 12.0% from the prior year. The company was profitable, with a net margin of 5.8% and a gross margin of 29.2%. It held $53.37M in total assets against $23.80M in total liabilities.
Key ratios (FY2025)
29.2%
Gross margin
2.9%
Operating margin
5.8%
Net margin
4.0%
Return on equity
-12.0%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | $20.69M | $23.50M | $19.82M | $19.19M | $20.76M | — |
| Cost of Revenue | $14.64M | $14.00M | $13.04M | $12.99M | $14.40M | — |
| Gross Profit | $6.04M | $9.50M | $6.78M | $6.20M | $6.36M | — |
| Operating Income | $608.2K | $3.64M | $2.87M | $2.13M | $2.63M | — |
| Net Income | $1.19M | $3.68M | $2.88M | $2.71M | $2.63M | — |
| EPS (Diluted) | $0.01 | $0.02 | $0.02 | $0.02 | $0.02 | — |
| Total Assets | $53.37M | $45.80M | $32.90M | $20.94M | — | — |
| Total Liabilities | $23.80M | $17.25M | $8.92M | $5.70M | — | — |
| Shareholders' Equity | $29.57M | $28.55M | $23.98M | $15.24M | $14.03M | $10.80M |
| Operating Cash Flow | $2.90M | -$1.21M | $3.11M | $1.58M | $5.84M | — |
| Capital Expenditures | $6.63M | $144.9K | $113.9K | $40.2K | $42.9K | — |
| Shares Outstanding | 156.55M | 156.47M | 145.14M | 135.00M | 135.00M | — |